Field evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis.
Valarie Sarah OpolloAlliance NikuzeJihane Ben-FarhatEmily AnyangoFelix HumwaBoaz OyaroStephen WanjalaWillis OmwoyoMaxwel MajiwaVictor AkeloClement ZehDavid MamanPublished in: PloS one (2018)
Our findings show that GeneXpert HIV-1 Qual performs well compared to CAP/CTM using DBS samples, suggesting that this technology may be adopted in decentralized laboratories as a near POC device. It may contribute to prompt diagnosis of HIV exposed infants hence enabling early linkage to care, thus advancing further gains in EID.